CAPTRUST Financial Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.7K Buy
+12,090
New +$28.4K ﹤0.01% 2952
2022
Q3
Sell
-897
Closed -$5K 2830
2022
Q2
$5K Hold
897
﹤0.01% 4080
2022
Q1
$17K Hold
897
﹤0.01% 3486
2021
Q4
$29K Sell
897
-646
-42% -$26K ﹤0.01% 3042
2021
Q3
$63K Sell
1,543
-9,354
-86% -$339K ﹤0.01% 2426
2021
Q2
$392K Buy
10,897
+9,900
+993% +$365K ﹤0.01% 1105
2021
Q1
$39K Buy
997
+497
+99% +$22.4K ﹤0.01% 2587
2020
Q4
$20K Sell
500
-525
-51% -$24.1K ﹤0.01% 2251
2020
Q3
$51K Buy
+1,025
New +$54.3K ﹤0.01% 1616

Other funds holding GDRX

CAPTRUST Financial Advisors's GDRX Position: Q1 2026 in Review

CAPTRUST Financial Advisors opened a new position in GoodRx Holdings (GDRX) in Q1 2026: 12,090 shares worth $23.7K. The stake represents ﹤0.01% of the portfolio and ranks #2952 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in GDRX as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in GDRX in Q3 2020 and has held it in 9 quarters since. The position peaked at $392K in Q2 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • CAPTRUST Financial Advisors held 12,090 shares of GoodRx Holdings worth $23.7K as of Q1 2026.
  • GoodRx Holdings was a new CAPTRUST Financial Advisors position in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2952 holding.
  • CAPTRUST Financial Advisors first reported a position in GoodRx Holdings in Q3 2020 and has held it in 9 quarters since.
  • CAPTRUST Financial Advisors's GoodRx Holdings position peaked at $392K in Q2 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.